DIVIDEND ANNOUNCEMENT: Lilly (Eli) & Co (NYSE:LLY) on 06/26/2023 declared a dividend of $1.1300 per share

Lilly (Eli) & Co (NYSE:LLY) on 06/26/2023 declared a dividend of $ 1.1300 per share payable on September 08, 2023 to shareholders of record as of August 15, 2023.

Lilly (Eli) & Co (NYSE:LLY) has paid dividends since 1885, has a current dividend yield of 0.9850928187% and has increased its dividends for 8 successive years.

Lilly (Eli) & Co's market cap is $ 435,564,423,320 and has a PE ratio of 72.95. The stock price closed yesterday at $ 458.84 and has a 52 week low/high of $ 296.32 and $ 462.26.

Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products and other therapies. Co.'s diabetes products include: Basaglar®, a long-acting human insulin analog for the treatment of diabetes; and Trajenta®, for the treatment of type 2 diabetes. Co.'s oncology products include: Alimta®, for treatment of patients with non-squamous cell histology and no epidermal growth factor receptor or anaplastic lymphoma kinase genomic tumor aberrations.

For more information on Lilly (Eli) & Co click here.